SEC Comment Letter for CYTOKINETICS INC (CYTK) (CIK 0001061983) (CYTK) — Oct 26, 2021

CYTOKINETICS INC (CYTK) (CIK 0001061983)
Date: Oct. 26, 2021 · CIK: 0001061983 · Accession: 0000000000-21-012975

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-50633

Date

October 26, 2021

Author

Ching Jaw

Form

UPLOAD

Company

CYTOKINETICS INC (CYTK) (CIK 0001061983)

Letter

United States securities and exchange commission logo October 26, 2021 Ching Jaw Senior Vice President, Chief Financial Officer Cytokinetics, Incorporated 280 East Grand Avenue South San Francisco, CA 94080 Re:Cytokinetics, Incorporated Form 10-K for the Fiscal Year Ended December 31, 2020 Filed February 26, 2021 File No. 000-50633 Dear Mr. Jaw: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

United States securities and exchange commission logo
October 26, 2021
Ching Jaw
Senior Vice President, Chief Financial Officer
Cytokinetics, Incorporated
280 East Grand Avenue
South San Francisco, CA 94080
Re:Cytokinetics, Incorporated
Form 10-K for the Fiscal Year Ended December 31, 2020
Filed February 26, 2021
File No. 000-50633
Dear Mr. Jaw:
            We have completed our review of your filings.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io